Kathryn B Holroyd1, Faisal Aziz2, Miklos Szolics3, Taoufik Alsaadi4, Michael Levy5, Nicoline Schiess5. 1. Partners Neurology Residency, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, Massachusetts, USA. 2. Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, United Arab Emirates. 3. Department of Neurology, Tawam Hospital, Al Ain, Abu Dhabi, United Arab Emirates. 4. Neurology Department, American Center for Psychiatry and Neurology, Al Ain, Abu Dhabi, United Arab Emirates. 5. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
OBJECTIVE: To determine the epidemiology and characteristics of transverse myelitis (TM) and neuromyelitis optica spectrum disorders (NMOSD) in Abu Dhabi, United Arab Emirates. METHODS: Retrospective chart review at four large government-run hospitals in Abu Dhabi between 2010 and 2016. Data collected included year of onset, presentation, laboratory results including aquaporin-4 immunoglobulin G (IgG)/myelin oligodendrocyte glycoprotein IgG antibodies and the occurrence of any relapses. RESULTS: A total of 46 individuals were identified. Of these, 23 (50%) were Emirati citizens. Within the overall group including pediatrics, the crude prevalence rate for monophasic TM was 1.0 per 100 000, and for NMOSD was 0.34 per 100 000. Incidence rates within the overall group for TM and NMOSD were 0.18 per 100 000 and 0.05 per 100 000, respectively. For Emirati citizens aged ≥20 years, the prevalence rate for monophasic TM was 2.46 per 100 000 and 1.76 per 100 000 for NMOSD, and the incidence was 0.57 per 100 000 and 0.17 per 100 000, respectively. The incidence of monophasic TM and NMOSD within the Emirati pediatric population (aged ≤19 years) was 0.18 per 100 000 and 0.06 per 100 000, respectively. The mean age of onset for monophasic TM was 36 years, and for NMOSD was 43 years. Nine patients had a positive aquaporin-4 IgG or anti-myelin oligodendrocyte glycoprotein IgG antibody result. Of the 30 participants with available laboratory cerebrospinal fluid analysis, 36.6% had elevated white blood counts (>5.0 × 106/L), and 43% had elevated protein levels. A total of 19 participants had documentation of oligoclonal bands or IgG index, and just four (21%) had either oligoclonal bands or elevated IgG index. CONCLUSION: The present study describes the epidemiology and characteristics of TM and NMOSD among populations in Abu Dhabi. The adult prevalence rate for Emirati citizens was 2.46 per 100 000 for monophasic TM, and 1.76 per 100 000 for NMOSD. The overall incidence was 0.18 per 100 000 and 0.05 per 100 000, respectively.
OBJECTIVE: To determine the epidemiology and characteristics of transverse myelitis (TM) and neuromyelitis optica spectrum disorders (NMOSD) in Abu Dhabi, United Arab Emirates. METHODS: Retrospective chart review at four large government-run hospitals in Abu Dhabi between 2010 and 2016. Data collected included year of onset, presentation, laboratory results including aquaporin-4 immunoglobulin G (IgG)/myelin oligodendrocyte glycoprotein IgG antibodies and the occurrence of any relapses. RESULTS: A total of 46 individuals were identified. Of these, 23 (50%) were Emirati citizens. Within the overall group including pediatrics, the crude prevalence rate for monophasic TM was 1.0 per 100 000, and for NMOSD was 0.34 per 100 000. Incidence rates within the overall group for TM and NMOSD were 0.18 per 100 000 and 0.05 per 100 000, respectively. For Emirati citizens aged ≥20 years, the prevalence rate for monophasic TM was 2.46 per 100 000 and 1.76 per 100 000 for NMOSD, and the incidence was 0.57 per 100 000 and 0.17 per 100 000, respectively. The incidence of monophasic TM and NMOSD within the Emirati pediatric population (aged ≤19 years) was 0.18 per 100 000 and 0.06 per 100 000, respectively. The mean age of onset for monophasic TM was 36 years, and for NMOSD was 43 years. Nine patients had a positive aquaporin-4 IgG or anti-myelin oligodendrocyte glycoprotein IgG antibody result. Of the 30 participants with available laboratory cerebrospinal fluid analysis, 36.6% had elevated white blood counts (>5.0 × 106/L), and 43% had elevated protein levels. A total of 19 participants had documentation of oligoclonal bands or IgG index, and just four (21%) had either oligoclonal bands or elevated IgG index. CONCLUSION: The present study describes the epidemiology and characteristics of TM and NMOSD among populations in Abu Dhabi. The adult prevalence rate for Emirati citizens was 2.46 per 100 000 for monophasic TM, and 1.76 per 100 000 for NMOSD. The overall incidence was 0.18 per 100 000 and 0.05 per 100 000, respectively.
Entities:
Keywords:
United Arab Emirates; incidence; neuromyelitis optica spectrum disorders; prevalence; transverse myelitis
Authors: Nicola P Klein; Paula Ray; Diane Carpenter; John Hansen; Edwin Lewis; Bruce Fireman; Steven Black; Claudia Galindo; Johannes Schmidt; Roger Baxter Journal: Vaccine Date: 2009-11-05 Impact factor: 3.641
Authors: J de Seze; T Stojkovic; G Breteau; C Lucas; U Michon-Pasturel; J Y Gauvrit; E Hachulla; F Mounier-Vehier; J P Pruvo; D Leys; A Destée; P Y Hatron; P Vermersch Journal: Brain Date: 2001-08 Impact factor: 13.501
Authors: B Banwell; J Kennedy; D Sadovnick; D L Arnold; S Magalhaes; K Wambera; M B Connolly; J Yager; J K Mah; N Shah; G Sebire; B Meaney; M-E Dilenge; A Lortie; S Whiting; A Doja; S Levin; E A MacDonald; D Meek; E Wood; N Lowry; D Buckley; C Yim; M Awuku; C Guimond; P Cooper; F Grand'Maison; J B Baird; V Bhan; A Bar-Or Journal: Neurology Date: 2009-01-20 Impact factor: 9.910
Authors: Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker Journal: Neurology Date: 2015-06-19 Impact factor: 9.910
Authors: Nirmeen A Kishk; Walaa Abdelfattah; Nevin M Shalaby; Hatem S Shehata; Amr Hassan; Mohamed I Hegazy; Noha T Abokrysha; Doaa Abdellatif; Shereen M Shawky; Sarah S Abdo; Noha Taha; Amr M Fouad; Alaa Elmazny; Amany H Ragab Journal: BMC Neurol Date: 2021-02-03 Impact factor: 2.474
Authors: Viktoria Papp; Melinda Magyari; Orhan Aktas; Thomas Berger; Simon A Broadley; Philippe Cabre; Anu Jacob; Jun-Ichi Kira; Maria Isabel Leite; Romain Marignier; Katsuichi Miyamoto; Jacqueline Palace; Albert Saiz; Maria Sepulveda; Olafur Sveinsson; Zsolt Illes Journal: Neurology Date: 2020-12-11 Impact factor: 9.910
Authors: Justin R Abbatemarco; Jonathan R Galli; Michael L Sweeney; Noel G Carlson; Verena C Samara; Haley Davis; Stefanie Rodenbeck; Ka-Ho Wong; M Mateo Paz Soldan; John E Greenlee; John W Rose; Alen Delic; Stacey L Clardy Journal: Neurol Neuroimmunol Neuroinflamm Date: 2021-08-31